ASX CODE: PCK
PainChek partners with Australia’s largest child health research institute to trial pain app in...
As part of its plan to expand its PainChek app to children worldwide, PainChek (ASX: PCK) has teamed up with the Melbourne Murdoch Children’s...
PainChek expands internationally with Person Centred Software UK distribution agreement
PainChek (ASX: PCK) has secured a binding distribution agreement with Person Centred Software paving the way for the company to launch its pain assessment...
Federal Government to invest $5m in PainChek’s app for dementia patients
Australian medical device company PainChek (ASX: PCK) is set to receive a $5 million grant from the Australian Federal Government to trial its pain...
PainChek signs licence agreement with Queensland aged care provider
Digital health company PainChek (ASX: PCK) has executed a licence agreement with Churches Of Christ in Queensland, which will give the aged care provider...
PainChek receives ePAT validation in peer-reviewed study
PainChek’s (ASX: PCK) proprietary pain-detection product has been officially validated by a peer-reviewed study and in added support towards its overall clinical usefulness in...
PainChek to secure FDA De Novo classification
Formerly ePat Technologies (ASX: EPT), medical device company PainChek (ASX: PCK) is on course to secure De Novo classification from the Food and Drug...
